AliveCor has launched KardiaACCESS, a no-cost program for Original Medicare Part B beneficiaries delivered under the CMS Innovation Center's 10-year ACCESS Model, now live in 48 states. The program treats cardiovascular, kidney and metabolic disease as a single interconnected syndrome rather than three separate diagnoses, combining connected ECG and blood pressure devices, virtual clinical visits and lifestyle coaching. Two tracks separate those with early risk markers from those with established disease, extending monitoring into the long intervals between conventional appointments.
Key Points
- Free Medicare program treats heart, kidney, metabolic disease as one syndrome
- Ten-year CMS model live across 48 states, two risk tracks
- Connected devices and coaching fill gaps between biannual clinical visits
Longevity Analysis
Cardio-kidney-metabolic disease progresses through feedback loops — elevated pressure strains filtration capacity, declining filtration burdens the heart, insulin resistance accelerates both — which makes isolated management of any single organ inefficient. Twice-yearly measurements cannot capture a slow drift in blood pressure or glucose; continuous data with clinical interpretation behind it converts scattered numbers into an actionable signal. The structural advance here is less technological than behavioral: removing cost as a barrier for the highest-risk population addresses the variable that most often determines whether a protocol is sustained long enough to alter trajectory.
Original published by Longevity.Technology, by Kyle Umipig.